X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs MYLAN (US) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   MYLAN
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
MYLAN
Dec-14
STERLING BIOTECH/
MYLAN
5-Yr Chart
Click to enlarge
High Rs114,137-   
Low Rs32,915-   
Sales per share (Unadj.) Rs26.81,416.2-  
Earnings per share (Unadj.) Rs-15.0170.6-  
Cash flow per share (Unadj.) Rs-5.5274.6-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.9704.0-  
Shares outstanding (eoy) m267.87378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x0.32.5 10.4%   
Avg P/E ratio x-0.520.7 -2.2%  
P/CF ratio (eoy) x-1.312.8 -9.9%  
Price / Book Value ratio x0.15.0 2.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,8621,334,143 0.1%   
No. of employees `0001.425.0 5.4%   
Total wages/salary Rs m5470-   
Avg. sales/employee Rs Th5,303.321,433.8 24.7%   
Avg. wages/employee Rs Th403.80-   
Avg. net profit/employee Rs Th-2,959.02,582.1 -114.6%   
INCOME DATA
Net Sales Rs m7,181535,845 1.3%  
Other income Rs m43-3,123 -1.4%   
Total revenues Rs m7,223532,722 1.4%   
Gross profit Rs m947133,267 0.7%  
Depreciation Rs m2,54339,355 6.5%   
Interest Rs m4,37723,114 18.9%   
Profit before tax Rs m-5,93167,675 -8.8%   
Minority Interest Rs m0-278 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,9242,846 -67.6%   
Profit after tax Rs m-4,00764,551 -6.2%  
Gross profit margin %13.224.9 53.0%  
Effective tax rate %32.44.2 771.6%   
Net profit margin %-55.812.0 -463.2%  
BALANCE SHEET DATA
Current assets Rs m14,335471,079 3.0%   
Current liabilities Rs m49,809368,289 13.5%   
Net working cap to sales %-494.019.2 -2,575.4%  
Current ratio x0.31.3 22.5%  
Inventory Days Days40378 516.7%  
Debtors Days Days171107 159.1%  
Net fixed assets Rs m55,432123,966 44.7%   
Share capital Rs m26818,949 1.4%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,701266,368 5.5%   
Long term debt Rs m9,478397,928 2.4%   
Total assets Rs m73,9881,072,905 6.9%  
Interest coverage x-0.43.9 -9.0%   
Debt to equity ratio x0.61.5 43.2%  
Sales to assets ratio x0.10.5 19.4%   
Return on assets %0.58.2 6.1%  
Return on equity %-27.324.2 -112.5%  
Return on capital %-6.413.6 -47.2%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,71970,437 2.4%  
From Investments Rs m-3,148-55,549 5.7%  
From Financial Activity Rs m1,426-18,560 -7.7%  
Net Cashflow Rs m-3-3,672 0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 69.41 Rs / USD

Compare STERLING BIOTECH With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: CADILA HEALTHCARE  WYETH LTD  SHASUN PHARMA  ALEMBIC LTD  ELDER PHARMA  



Today's Market

Indian Indices Continue Downtrend; Sensex Ends 495 Points Lower(Closing)

Indian share markets witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

Stocks that Could Be Out of Reach Post Elections(The 5 Minute Wrapup)

Apr 9, 2019

It's a matter of time before the stocks catch the fancy of the markets and big investors.

3 Indian Stocks with Amazon-Like Potential(Profit Hunter)

Apr 10, 2019

We have identified 3 stocks with huge wealth building potential which meet our 'Click of a Button' criteria.

This Company is Making a Big Comeback and You Can Now Profit from Its Example(The 5 Minute Wrapup)

Apr 10, 2019

How Dell got its mojo back.

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Nov 5, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 5-YR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS